Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Milieu Teaching-AV (MT-AV Pilot) [NA]
The Milieu Teaching-AV (MT-AV Pilot) trial sponsored by Father Flanagan's Boys' Home, for autism spectrum disorder, has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-13Clinical Trial Update: Vagus Nerve Stimulator for Autism and Other Developmental Disorders [NA]
A clinical trial evaluating a vagus nerve stimulator for autism and other developmental disorders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Mechanism Study of Sulforaphane in ASD Improvement [NA]
A clinical trial investigating the mechanism by which sulforaphane could affect Autism Spectrum Disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-08Clinical Trial Update: Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder
Clinical Trial Update notes that a single-patient study evaluating vancomycin with fecal microbiota transplant for Autism Spectrum Disorder …
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism
A non-interventional pilot trial sponsored by ProgenaBiome investigating gut flora and autism has been withdrawn from ClinicalTrials.gov.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-04-24Clinical Trial Update: Non-invasive Brain Stimulation in Children With Autism [NA]
A clinical trial studying non-invasive brain stimulation in children with autism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-08Clinical Trial Update: A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder [Phase 2]
Jazz Pharmaceuticals has withdrawn its Phase 2 trial of JZP541 in adults with irritability associated with autism spectrum disorder.
-
CLINICAL_TRIALS withdrawal · 2024-09-26Clinical Trial Update: A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum Disorders [Phase 2]
A Phase 2 pilot trial of buspirone for anxiety in youth with autism spectrum disorders has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Feasibility of Mobile Game System for Potential Treatment of Developmental Delays [NA]
Clinical trial evaluating a mobile game system for autism spectrum disorder has been withdrawn. The study is inactive with no reported resul…
-
CLINICAL_TRIALS withdrawal · 2024-08-23Clinical Trial Update: Telehealth Autism Assessment for Adults [NA]
A Vanderbilt University Medical Center-sponsored clinical trial evaluating telehealth autism assessment for adults has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-07-25Clinical Trial Update: Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder [Phase 3]
A Phase 3 trial evaluating bumetanide oral liquid in children and adolescents with autism spectrum disorder has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-06-28Clinical Trial Update: Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders [Phase 2]
Phase 2 double-blind trial of buspirone for treating anxiety in youth with Autism Spectrum Disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-03-12Clinical Trial Update: Efficacy and Safety of Slenyto for Insomnia in Children With ASD [Phase 3]
Phase 3 trial investigating Slenyto for insomnia in children with autism was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-04-24Clinical Trial Update: Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine [Phase 2]
Clinical trial update on a Phase 2 withdrawal study of memantine in pediatric patients with autism spectrum disorders after prior memantine …
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Adipose Derived Stem Cell Therapy for Autism [Phase 1, Phase 2]
A clinical trial evaluating adipose-derived stem cell therapy for autism was withdrawn from Phase 1/Phase 2.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG [Phase 2]
Phase 2 trial of divalproex sodium in children with autism spectrum disorder and epileptiform EEG has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-08Clinical Trial Update: Cortical Metrics Assessment Outcome Measure Development in Autism With Memantine Treatment
A clinical trial investigating memantine for autism with cortical metrics outcome measures has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-02Clinical Trial Update: Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder [Phase 2]
A Phase 2 clinical trial evaluating clonidine for sleep disturbances in children with autism spectrum disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-21Clinical Trial Update: Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium [Phase 2]
A Phase 2 clinical trial evaluating divalproex sodium for children with autism spectrum disorders and epileptiform EEG was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen [NA]
The ClinicalTrials.gov entry for an open-label trial of intrathecal baclofen for severe tactile defensiveness in autism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-04Clinical Trial Update: Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response [NA]
A clinical trial investigating propranolol for autism in adults and adolescents has been withdrawn, with no results reported.
-
CLINICAL_TRIALS withdrawal · 2016-08-25Clinical Trial Update: Cortical Metrics in Intervention Trials With Autism Spectrum Disorders [Phase 2, Phase 3]
The clinical trial update notes that the Phase 2/3 cortical metrics intervention trials for autism spectrum disorder have been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-09Clinical Trial Update: Treatment Resistant Epilepsy and N-Acetyl Cysteine [NA]
A clinical trial investigating N-Acetyl Cysteine for treatment-resistant epilepsy in autism with irritability has been withdrawn; no results…
-
CLINICAL_TRIALS withdrawal · 2015-03-13Clinical Trial Update: Diffusion Tensor Imaging in Autism [NA]
A clinical trial titled 'Diffusion Tensor Imaging in Autism' (NCT00382382) sponsored by the University of Florida has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-18Clinical Trial Update: Mercury Chelation to Treat Autism [Phase 2]
A Phase 2 clinical trial evaluating mercury chelation for autism sponsored by the National Institute of Mental Health has been withdrawn.